Expression of bone morphogenetic protein 9 and insulin-like growth factor-1 in different molecular subtypes of breast cancer and their correlations with clinical features

GUI Zhaohua; WU Jing; LI Xiaojie; YAN Hong

doi:10.7619/jcmp.20210079

Journal of Clinical Medicine in Practice > 2021 > 25(8): 1-5, 10. > DOI: 10.7619/jcmp.20210079

GUI Zhaohua, WU Jing, LI Xiaojie, YAN Hong. Expression of bone morphogenetic protein 9 and insulin-like growth factor-1 in different molecular subtypes of breast cancer and their correlations with clinical features[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 1-5, 10. DOI: 10.7619/jcmp.20210079

Citation:

PDF (763 KB)

Expression of bone morphogenetic protein 9 and insulin-like growth factor-1 in different molecular subtypes of breast cancer and their correlations with clinical features

GUI Zhaohua^{1, 2},
WU Jing^{1, 2},
LI Xiaojie^{1, 2},
YAN Hong^{1, 2, ,}

1.
Clinical Pathology Centre, First Affiliated Hospital of University of Science and Techndogy of China, Hefei, Anhui, 230001
2.
Department of Pathology, West Division of First Affiliated Hospital of University of Science and Techndogy of China, Anhui Provincial Cancer Hospital, Hefei, Anhui, 230001

More Information

Received Date: January 04, 2021
Available Online: April 29, 2021
Published Date: April 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the expression of bone morphogenetic protein 9 (BMP-9)and insulin-like growth factor-1(IGF-1) in different molecular subtypes of breast cancer and their correlations with clinical features.
Methods A total of 98 breast cancer patients were divided into Luminal A type group (n=23), Luminal B type group (n=26), HER-2 overexpression type group (n=24), Basal-like type group (n=25) according to different molecular subtypes of breast cancer. The expression levels of BMP-9 and IGF-1 of four groups were compared, and the relationships between the expression levels of BMP-9 as well as IGF-1 and clinical signs were analyzed.
Results In 98 cases of breast cancer, BMP-9 was negatively expressed in 36 cases and positively expressed in 62 cases. BMP-9 mRNA level and BMP-9 protein positive rate in the HER-2 overexpression type group and the Basal-like type group were significantly lower than those in the Luminal A type group and the Luminal B type group, and the Luminal B type group was significantly lower than that in the Luminal A type group (P < 0.05). In 98 cases of breast cancer, IGF-1 was negatively expressed in 36 cases and positively expressed in 62 cases. IGF-1 mRNA level and IGF-1 protein positive rate in the HER-2 overexpression type group and the Basal-like type group were significantly higher than those in the Luminal A and Luminal B type groups, and the Luminal B type group was significantly higher than that in the Luminal A type group (P < 0.05). The expression of BMP-9 was negatively correlated with tumor diameter, the number of lymph node metastasis and TNM staging; the expression of IGF-1 was positively correlated with tumor diameter, the number of lymph node metastasis and TNM staging.
Conclusion The expressions of BMP-9 and IGF-1 are related to the clinical molecular subtypes of breast cancer patients. In clinical practice, BMP-9 and IGF-1 can be included in the detection of breast cancer to predict the clinical treatment effect of patients.
- bone morphogenetic protein 9,
- insulin-like growth factor-1,
- molecular subtypes,
- breast cancer,
- correlation research

FullText(HTML)

References (21)

References

[1]	刘军, 王伟, 陈成玲. 乳腺癌术后上肢淋巴水肿的危险因素分析[J]. 肿瘤学杂志, 2018, 24(1): 70-73. https://www.cnki.com.cn/Article/CJFDTOTAL-XHON201801020.htm
[2]	张璐璐, 刘芸, 段文冰, 等. 乳腺癌患者部分外周血指标的变化及肿瘤标志物的诊断价值[J]. 中国医药, 2018, 13(3): 421-425. doi: 10.3760/cma.j.issn.1673-4777.2018.03.025
[3]	周源, 许庆勇, 尹惠子. 乳腺癌分子分型与放射治疗相关性的研究进展[J]. 现代肿瘤医学, 2020, 28(5): 844-847. doi: 10.3969/j.issn.1672-4992.2020.05.036
[4]	马新宇, 曹中伟. HER2阳性乳腺癌曲妥珠单抗耐药性的研究进展[J]. 癌症进展, 2020, 18(1): 11-13, 108. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ202001004.htm
[5]	夏菁, 苟理尧, 刘梦瑶, 等. BMP9通过调控AMPK信号通路抑制乳腺癌细胞脂质代谢及脂质利用[J]. 中国细胞生物学学报, 2018, 40(7): 1072-1079. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZZ201807002.htm
[6]	沈坤炜. 乳腺癌临床诊治实用手册[M]. 上海: 上海科学技术文献出版社, 2013: 23-27.
[7]	高军喜, 马方婧, 杨磊, 等. 不同分子亚型乳腺癌超声造影特征及定量参数对比研究[J]. 中国临床医学影像杂志, 2019, 30(4): 261-266. https://www.cnki.com.cn/Article/CJFDTOTAL-LYYX201904011.htm
[8]	HODGSON J, SWIETLIK E M, SALMON R M, et al. Characterization of GDF2 mutations and levels of BMP9 and BMP10 in pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2020, 201(5): 575-585. doi: 10.1164/rccm.201906-1141OC
[9]	MAASS A, DVZEL S, BRIGADSKI T, et al. Relationships of peripheral IGF-1, VEGF and BDNF levels to exercise-related changes in memory, hippocampal perfusion and volumes in older adults[J]. Neuroimage, 2016, 131: 142-154. doi: 10.1016/j.neuroimage.2015.10.084
[10]	王美, 张琦, 杜琛, 等. 肩梯在乳腺癌改良根治术后患者患肢功能锻炼中的应用及效果[J]. 解放军护理杂志, 2018, 35(7): 59-62. https://www.cnki.com.cn/Article/CJFDTOTAL-JFHL201807019.htm
[11]	任虹, 于丽, 叶江. 多层螺旋CT、超声及X射线扫描对乳腺癌诊断作用分析[J]. 实用医院临床杂志, 2018, 15(4): 121-123. https://www.cnki.com.cn/Article/CJFDTOTAL-YYLC201804041.htm
[12]	王建华, 王红昆, 李辉, 等. 1.5 T MRI结合数字化X线钼靶在乳腺癌诊断、TNM分期及疗效评估中的应用价值[J]. 中国医师杂志, 2019, 21(1): 134-136. https://www.cnki.com.cn/Article/CJFDTOTAL-DLZS201607019.htm
[13]	刘静, 陈霰, 陈敬一, 等. 彩色多普勒超声早期诊断乳腺癌腋窝淋巴结转移的应用效果及灵敏度、特异度分析[J]. 中国妇幼保健, 2020, 35(2): 357-359. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202002052.htm
[14]	张婧姝, 郑慧. 彩色多普勒超声诊断乳腺癌的价值[J]. 安徽医药, 2018, 22(8): 1475-1477, 1644. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY201808013.htm
[15]	唐少虎, 李香营. 超声及MRI诊断不同分子亚型乳腺癌的效果及对患者预后质量的影响[J]. 广东医学, 2018, 39(S2): 173-175, 178. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX2018S2058.htm
[16]	LI S, DAI H Y, HE Y, et al. BMP9 inhibits the growth of breast cancer cells by downregulation of the PI3K/Akt signaling pathway[J]. Oncol Rep, 2018, 40(3): 1743-1751. http://www.researchgate.net/publication/326379550_BMP9_inhibits_the_growth_of_breast_cancer_cells_by_downregulation_of_the_PI3KAkt_signaling_pathway
[17]	CHOUCAIR A, PHAM T H, OMARJEE S, et al. The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer[J]. Oncogene, 2019, 38(21): 4015-4027. http://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsRW5nTmV3UzIwMjEwMzAyEiA1NGI0MzNiYWYwMzIyYmVkMWRhMWE0ZGFkYjQyMmU0MRoIenJ5bzdmdWQ%3D
[18]	CHI L H, BURROWS A D, ANDERSON R L. Bone morphogenetic protein signaling in breast cancer progression[J]. Growth Factors, 2019, 37(1/2): 12-28.
[19]	LIU Y, CHEN M, ZHAO X, et al. Bone morphogenetic protein 6 expression in cumulus cells is negatively associated with oocyte maturation[J]. Hum Fertil (Camb), 2019: 1-8. http://www.ncbi.nlm.nih.gov/pubmed/31495245
[20]	薛晶, 赵杨, 程玉, 等. IGF-1在乳腺癌中的表达与临床意义[J]. 承德医学院学报, 2018, 35(2): 99-101. https://www.cnki.com.cn/Article/CJFDTOTAL-CDYX201802005.htm
[21]	CHEN L, ZOU X, ZHANG R X, et al. IGF1 potentiates BMP9-induced osteogenic differentiation in mesenchymal stem cells through the enhancement of BMP/Smad signaling[J]. BMB Rep, 2016, 49(2): 122-127. http://europepmc.org/articles/PMC4915116/

Cited By

Cited by

Periodical cited type(1)

许丽，陈竟男. 丙泊酚联合舒适化护理在老年患者无痛胃镜检查中的效果. 吉林医学. 2024(09): 2239-2241 .

Other cited types(0)

Get Citation

PDF

XML

Article views (390) PDF downloads (58) Cited by(1)

Turn off MathJax

Article Contents

Abstract

References

Expression of bone morphogenetic protein 9 and insulin-like growth factor-1 in different molecular subtypes of breast cancer and their correlations with clinical features

Abstract

References

Cited by

Periodical cited type(1)

Other cited types(0)

Catalog

Export File

Citation

Format

Content